First-trimester placentation and the risk of antepartum stillbirth.

CONTEXT Preterm birth and low birth weight are determined, at least in part, during the first trimester of pregnancy. However, it is unknown whether the risk of stillbirth is also determined during the first trimester. OBJECTIVE To determine whether the risk of antepartum stillbirth varies in relation to circulating markers of placental function measured during the first trimester of pregnancy. DESIGN, SETTING, AND PARTICIPANTS Multicenter, prospective cohort study (conducted in Scotland from 1998 through 2000) of 7934 women who had singleton births at or after 24 weeks' gestation, who had blood taken during the first 10 weeks after conception, and who were entered into national registries of births and perinatal deaths. MAIN OUTCOME MEASURES Antepartum stillbirths and stillbirths due to specific causes. RESULTS There were 8 stillbirths among the 400 women with levels of pregnancy-associated plasma protein A (PAPP-A) in the lowest fifth percentile compared with 17 among the remaining 7534 women (incidence rate per 10,000 women per week of gestation: 13.4 vs 1.4, respectively; hazard ratio [HR], 9.2 [95% confidence interval [CI], 4.0-21.4]; P<.001). When analyzed by cause of stillbirth, low level of PAPP-A was strongly associated with stillbirth due to placental dysfunction, defined as abruption or unexplained stillbirth associated with growth restriction (incidence rate: 11.7 vs 0.3, respectively; HR, 46.0 [95% CI, 11.9-178.0]; P<.001), but was not associated with other causes of stillbirth (incidence rate: 1.7 vs 1.1, respectively; HR, 1.4 [95% CI, 0.2-10.6]; P = .75). There was no relationship between having a low level of PAPP-A and maternal age, ethnicity, parity, height, body mass index, race, or marital status. Adjustment for maternal factors did not attenuate the strength of associations observed. There was no association between maternal circulating levels of the free beta subunit of human chorionic gonadotropin and stillbirth risk. CONCLUSION The risk of stillbirth in late pregnancy may be determined by placental function in the first 10 weeks after conception.

[1]  B. Ong,et al.  Severe fetal bradycardia in a pregnant surgical patient despite normal oxygénation and blood pressure , 2003, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[2]  T. Tulandi,et al.  Laparoscopic Surgery in Pregnancy , 2003, Clinical obstetrics and gynecology.

[3]  J. Haddow,et al.  REFINEMENTS IN MANAGING MATERNAL WEIGHT ADJUSTMENT FOR INTERPRETING PRENATAL SCREENING RESULTS , 1996, Prenatal diagnosis.

[4]  P. Crowley,et al.  Interventions for preventing or improving the outcome of delivery at or beyond term. , 2006, The Cochrane database of systematic reviews.

[5]  J. G. Fuller,et al.  Epidural morphine for analgesia after Caesarean section: a report of 4880 patients , 1990, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[6]  L. Giudice,et al.  Pregnancy‐associated plasma protein‐A (PAPP‐A) cleaves insulin‐like growth factor binding protein (IGFBP)‐5 independent of IGF: implications for the mechanism of IGFBP‐4 proteolysis by PAPP‐A , 2001, FEBS letters.

[7]  Z Alfirevic,et al.  Doppler ultrasound for fetal assessment in high risk pregnancies , 2010 .

[8]  Steve N Caritis,et al.  Elective single-embryo transfer versus double-embryo transfer in in vitro fertilization , 2004, The New England journal of medicine.

[9]  Gordon C. S. Smith,et al.  Life-table analysis of the risk of perinatal death at term and post term in singleton pregnancies. , 2001, American journal of obstetrics and gynecology.

[10]  Gordon C. S. Smith,et al.  Early pregnancy levels of pregnancy-associated plasma protein a and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth. , 2002, The Journal of clinical endocrinology and metabolism.

[11]  J. Connor,et al.  Combined ultrasound and biochemical screening for Down's Syndrome in the first trimester: a Scottish multicentre study , 2002, BJOG : an international journal of obstetrics and gynaecology.

[12]  P. Grambsch,et al.  Proportional hazards tests and diagnostics based on weighted residuals , 1994 .

[13]  M. McNay,et al.  First-trimester growth and the risk of low birth weight. , 1998, The New England journal of medicine.

[14]  P. Yudkin,et al.  RISK OF UNEXPLAINED STILLBIRTH AT DIFFERENT GESTATIONAL AGES , 1987, The Lancet.

[15]  B. Källén,et al.  Laparoscopy during pregnancy: a study of five fetal outcome parameters with use of the Swedish Health Registry. , 1997, American journal of obstetrics and gynecology.

[16]  S. Emerson,et al.  Dose-response relationship of intrathecal morphine for postcesarean analgesia. , 1999, Anesthesiology.

[17]  H. Boshuizen,et al.  Multiple imputation of missing blood pressure covariates in survival analysis. , 1999, Statistics in medicine.

[18]  P. McLoone,et al.  Deprivation and mortality in Scotland, 1981 and 1991 , 1994, BMJ.

[19]  L. Gurrin,et al.  An audit of epidural blood patch after accidental dural puncture with a Tuohy needle in obstetric patients. , 2001, International journal of obstetric anesthesia.

[20]  J. Seebacher,et al.  Effectiveness of Epidural Blood Patch in the Management of Post–Dural Puncture Headache , 2001, Anesthesiology.

[21]  A. Macarthur Craniotomy for suprasellar meningioma during pregnancy: Role of fetal monitoring , 2004, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[22]  L. Giudice,et al.  Role of the IGF system in trophoblast invasion and pre-eclampsia. , 1999, Human reproduction.

[23]  I. Russell,et al.  Intrathecal diamorphine compared with morphine for postoperative analgesia after caesarean section under spinal anaesthesia. , 1998, British journal of anaesthesia.

[24]  P. Brownridge Spinal anaesthesia in obstetrics. , 1991, British journal of anaesthesia.

[25]  A. C. Primavesi,et al.  Intraoperative and Postoperative Analgesic Efficacy and Adverse Effects of Intrathecal Opioids in Patients Undergoing Cesarean Section with Spinal Anesthesia A Qualitative and Quantitative Systematic Review of Randomized Controlled Trials , 2000 .

[26]  Douglas G Altman,et al.  Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls , 2002, The Lancet.

[27]  C. Oxvig,et al.  Localization of pregnancy-associated plasma protein-A and colocalization of pregnancy-associated plasma protein-A messenger ribonucleic acid and eosinophil granule major basic protein messenger ribonucleic acid in placenta. , 1994, Laboratory investigation; a journal of technical methods and pathology.

[28]  S. Cnattingius,et al.  The epidemiology of stillbirth. , 2002, Seminars in perinatology.

[29]  G. Lyons,et al.  Minimum dose of intrathecal diamorphine required to prevent intraoperative supplementation of spinal anaesthesia for Caesarean section. , 2003, British journal of anaesthesia.

[30]  G. Hill,et al.  Time vs. success rate for epidural blood patch. , 1978, Anesthesiology.

[31]  B. Källén,et al.  Reproductive outcome after anesthesia and operation during pregnancy: A registry study of 5405 cases , 1989, American journal of obstetrics and gynecology.

[32]  W. Fawcett,et al.  Efficacy of epidural blood patch in the obstetric population. , 1999, International journal of obstetric anesthesia.

[33]  Metalloproteinase pregnancy-associated plasma protein A is a critical growth regulatory factor during fetal development , 2004, Development.